Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
about
Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Does Angiotensin-Converting En ...... al Practice Research Datalink.
@en
type
label
Does Angiotensin-Converting En ...... al Practice Research Datalink.
@en
prefLabel
Does Angiotensin-Converting En ...... al Practice Research Datalink.
@en
P2093
P2860
P356
P1433
P1476
Does Angiotensin-Converting En ...... cal Practice Research Datalink
@en
P2093
Katherine A McGlynn
Katrina Wilcox Hagberg
Vikrant V Sahasrabuddhe
P2860
P304
P356
10.1002/PHAR.1704
P407
P50
P577
2016-02-05T00:00:00Z